Skip to main content
. 2021 Oct 21;6(4):e21.00085. doi: 10.2106/JBJS.OA.21.00085

TABLE V.

Effectiveness of GAE as Assessed by VAS and WOMAC Scores

Month Reduction in VAS Pain Score (no. [%]) Reduction in WOMAC Pain Score (no. [%]) Reduction in WOMAC Total Score (no. [%])
≥25% ≥50% ≥75% ≥25% ≥50% ≥75% ≥25% ≥50% ≥75%
1 31 (78) 24 (60) 12 (30) 28 (70) 21 (53) 10 (25) 28 (70) 22 (55) 8 (20)
3 31 (78) 25 (63) 15 (38) 30 (75) 24 (60) 15 (38) 34 (85) 27 (68) 16 (40)
6 36 (90) 30 (75) 16 (40) 32 (80) 25 (63) 15 (38) 33 (83) 25 (68) 14 (35)
12 34 (85) 27 (68) 17 (43) 35 (88) 27 (68) 15 (38) 34 (85) 27 (68) 17 (43)